Serina Therapeutics, Inc. — Form D/A
Serina Therapeutics, Inc. of HUNTSVILLE, AL, a company, filed a Form D amendment with the SEC on 2018-04-13. The offering totals $32.5M, of which $8.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-04-13
- Form: D/A
- Accession: 0001558525-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $32.5M
- Amount sold: $8.2M
- Remaining: $24.3M
- Investors: 18
- Date of first sale: 2017-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-279933
Issuer
- Name: Serina Therapeutics, Inc.
- CIK: 0001558525
- Entity type: Corporation
- Jurisdiction: ALABAMA
- Address: 601 GENOME WAY, HUNTSVILLE, AL, 35806
- Phone: 2563270566
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Brendan A Rae | Executive Officer | Huntsville, AL |
| Barbara M Fisk | Director | Harvest, AL |
| James R Hudson, Jr. | Director | Huntsville, AL |
| Randall W Moreadith | Director | Huntsville, AL |
| Randall W Moreadith | Executive Officer | Huntsville, AL |
| Steve H Ledger | Director | Mill Valley, CA |
| Greg H Bailey, M.D. | Director | Sliema, O1 |
| J Milton Harris | Director | Huntsville, AL |
| J Milton Harris | Executive Officer | Huntsville, AL |
| Tacey R Viegas | Executive Officer | Madison, AL |
| Michael D Bentley | Director | Huntsville, AL |
| Michael D Bentley | Executive Officer | Huntsville, AL |
| Miguel A Loya | Director | Houston, TX |
| Barbara Milton Fisk | Director | Madison, AL |
| Lonnie S McMillian | Director | Madison, AL |
Other filings by this issuer (15)
More